Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Open-Label Rollover Study of PBI 4050 in Subjects With Alström Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03184584
Recruitment Status : Enrolling by invitation
First Posted : June 12, 2017
Last Update Posted : April 10, 2018
Sponsor:
Information provided by (Responsible Party):
ProMetic BioSciences Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Enrolling by invitation
  Estimated Primary Completion Date : July 2020
  Estimated Study Completion Date : September 2020